Skip to main content

JAK/TYK2

REstream Block (Upcoming)

        Day 4 was a half day closeout to the EULAR 2023 Congress. For me the big presentations were the late breaking abstracts, although there were other review and abstract sessions for those remaining.…
        An update on JAK inhibitors and cardiovascular risks

        Dr. Antoni Chan ( @synovialjoints ) shares #EULAR23 developments
        1 year 3 months ago
        An update on JAK inhibitors and cardiovascular risks Dr. Antoni Chan ( @synovialjoints ) shares #EULAR23 developments on JAK/TYK2 inhibitors. https://t.co/VovWE2OuXW https://t.co/QXKZLh5RuK
        EULAR 2023 Day 4 Recap
        Upadacitinib in SLE
        Daily Recap: Day Three EULAR 2023
        Should JAKs be ‘Tyk’ed off?
        RT @bella_mehta: Abstracts talking about #RA and JAKs and Biologic comparisons
        Huge number of pts to analyze this aftrr
        1 year 3 months ago
        Abstracts talking about #RA and JAKs and Biologic comparisons Huge number of pts to analyze this aftrr the initial NEJM study. Abstract summary pics below @RheumNow https://t.co/jl5S4fLq19